Cargando…

Characterization of in vivo tumorigenicity tests using severe immunodeficient NOD/Shi-scid IL2Rγ(null) mice for detection of tumorigenic cellular impurities in human cell-processed therapeutic products

The contamination of human cell-processed therapeutic products (hCTPs) with tumorigenic cells is one of the major concerns in the manufacturing and quality control of hCTPs. However, no quantitative method for detecting the tumorigenic cellular impurities is currently standardized. NOD/Shi-scid IL2R...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kusakawa, Shinji, Machida, Kazuhiko, Yasuda, Satoshi, Takada, Nozomi, Kuroda, Takuya, Sawada, Rumi, Okura, Hanayuki, Tsutsumi, Hideki, Kawamata, Shin, Sato, Yoji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Japanese Society for Regenerative Medicine 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6581766/ https://www.ncbi.nlm.nih.gov/pubmed/31245439 http://dx.doi.org/10.1016/j.reth.2014.12.001

Ejemplares similares

Ultra-sensitive detection of tumorigenic cellular impurities in human cell-processed therapeutic products by digital analysis of soft agar colony formation
por: Kusakawa, Shinji, et al.
Publicado: (2015)

Tumorigenicity-associated characteristics of human iPS cell lines
por: Yasuda, Satoshi, et al.
Publicado: (2018)

Comparison of biological features between severely immuno-deficient NOD/Shi-scid Il2rg(null) and NOD/LtSz-scid Il2rg(null) mice
por: Nagatani, Mariko, et al.
Publicado: (2019)

Incidence of spontaneous lymphomas in non-experimental NOD/Shi-scid, IL-2Rγ(null) (NOG) mice
por: Yasuda, Masahiko, et al.
Publicado: (2017)

Spontaneous granulocytic leukemia in a NOD/Shi-scid IL-2Rγ(null) mouse
por: Akane, Hirotoshi, et al.
Publicado: (2021)

Neither epithelial nor mesenchymal circulating tumor cells isolated from breast cancer patients are tumorigenic in NOD-scid Il2rg(null) mice
por: Donnenberg, Vera S, et al.
Publicado: (2016)

Differential Secondary Reconstitution of In Vivo-Selected Human SCID-Repopulating Cells in NOD/SCID versus NOD/SCID/γ chain(null) Mice
por: Cai, Shanbao, et al.
Publicado: (2011)

Human osteoclastogenesis in Epstein-Barr virus-induced erosive arthritis in humanized NOD/Shi-scid/IL-2Rγ(null) mice
por: Nagasawa, Yosuke, et al.
Publicado: (2021)

Application of cell growth analysis to the quality assessment of human cell-processed therapeutic products as a testing method for immortalized cellular impurities
por: Hasebe-Takada, Nozomi, et al.
Publicado: (2016)

Assessment of Benzene-Induced Hematotoxicity Using a Human-Like Hematopoietic Lineage in NOD/Shi-scid/IL-2Rγ(null) Mice
por: Takahashi, Masayuki, et al.
Publicado: (2012)

In vivo Effects of a Histone Deacetylase Inhibitor, FK228, on Human Acute Promyelocytic Leukemia in NOD/Shi‐scid/scid Mice
por: Kosugi, Hiroshi, et al.
Publicado: (2001)

Expression and in vitro assessment of tumorigenicity for NOD1 and NOD2 receptors in breast cancer cell lines
por: Velloso, Fernando J., et al.
Publicado: (2018)

Differential Post-Surgical Metastasis and Survival in SCID, NOD-SCID and NOD-SCID-IL-2Rγ(null) Mice with Parental and Subline Variants of Human Breast Cancer: Implications for Host Defense Mechanisms Regulating Metastasis
por: Milsom, Chloe C., et al.
Publicado: (2013)

Identification of a Gene Encoding Slow Skeletal Muscle Troponin T as a Novel Marker for Immortalization of Retinal Pigment Epithelial Cells
por: Kuroda, Takuya, et al.
Publicado: (2017)

Fracture Healing Is Delayed in Immunodeficient NOD/scid‑IL2Rγ(c)(null) Mice
por: Rapp, Anna E., et al.
Publicado: (2016)

Rapamycin Response in Tumorigenic and Non-Tumorigenic Hepatic Cell Lines
por: Jimenez, Rosa H., et al.
Publicado: (2009)

Evaluation of the reproducibility and positive controls of cellular immortality test for the detection of immortalized cellular impurities in human cell-processed therapeutic products
por: Hirai, Takamasa, et al.
Publicado: (2022)

Upregulation of NOD1 and NOD2 contribute to cancer progression through the positive regulation of tumorigenicity and metastasis in human squamous cervical cancer
por: Zhang, Yuanyuan, et al.
Publicado: (2022)

Tumorigenicity of acridine orange.
por: Van Duuren, B. L., et al.
Publicado: (1969)

NOD2 deficiency confers a pro‐tumorigenic macrophage phenotype to promote lung adenocarcinoma progression
por: Wang, Yibei, et al.
Publicado: (2021)

Recovery and Biodistribution of Ex Vivo Expanded Human Erythroblasts Injected into NOD/SCID/IL2Rγ(null) mice
por: Ghinassi, Barbara, et al.
Publicado: (2011)

Successful Establishment of an Orthotopic Hepatoblastoma In Vivo Model in NOD/LtSz-scid IL2Rγnull Mice
por: Ellerkamp, Verena, et al.
Publicado: (2011)

Correlation Between Genetic Abnormalities in Induced Pluripotent Stem Cell-Derivatives and Abnormal Tissue Formation in Tumorigenicity Tests
por: Yamamoto, Takako, et al.
Publicado: (2022)

The free cytoplasmic calcium concentration of tumorigenic and non-tumorigenic human somatic cell hybrids.
por: Banyard, M. R., et al.
Publicado: (1985)

Characteristics of surfactant proteins in tumorigenic and inflammatory lung lesions in rodents
por: Yokohira, Masanao, et al.
Publicado: (2018)

Enhanced development of functional human NK cells in NOD‐ scid‐IL2rg(null) mice expressing human IL15
por: Aryee, Ken‐Edwin, et al.
Publicado: (2022)

Tumorigenicity and lysis by natural killers
Publicado: (1981)

Tumorigenicity of RTK/RAS in urothelium
por: Wu, Xue-Ru, et al.
Publicado: (2015)

The integrity of chemically treated plasmid DNA as a chemical-based choice for prion clearance
por: Takada, Nozomi, et al.
Publicado: (2020)

Xenogeneic Graft-versus-Host-Disease in NOD-scid IL-2Rγ(null) Mice Display a T-Effector Memory Phenotype
por: Ali, Niwa, et al.
Publicado: (2012)

Membrane-type 1 matrix metalloproteinase-mediated progelatinase A activation in non-tumorigenic and tumorigenic humaneratinocytes
por: Baumann, P, et al.
Publicado: (2000)

Metabolomic and Mitochondrial Fingerprinting of the Epithelial-to-Mesenchymal Transition (EMT) in Non-Tumorigenic and Tumorigenic Human Breast Cells
por: Cuyàs, Elisabet, et al.
Publicado: (2022)

Reevaluation of NOD/SCID Mice as NK Cell-Deficient Models
por: Miao, Miao, et al.
Publicado: (2021)

A tumorigenic culprit in ES cells
por: Wells, William A.
Publicado: (2003)

Tumorigenicity of a combination of psoriasis therapies.
por: Phillips, D. H., et al.
Publicado: (1994)

Snail depletes the tumorigenic potential of glioblastoma
por: Savary, K, et al.
Publicado: (2013)

Neural stemness contributes to cell tumorigenicity
por: Xu, Liyang, et al.
Publicado: (2021)

KLK3 in the Regulation of Angiogenesis—Tumorigenic or Not?
por: Koistinen, Hannu, et al.
Publicado: (2021)

Suppression of Cell Tumorigenicity by Non-neural Pro-differentiation Factors via Inhibition of Neural Property in Tumorigenic Cells
por: Yang, Xiaoli, et al.
Publicado: (2021)

NOD/scid IL-2Rg(null )mice: a preclinical model system to evaluate human dendritic cell-based vaccine strategies in vivo
por: Spranger, Stefani, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_of2jht2t676vi82hbgr95svhib